406,354 Shares in Ventas, Inc. $VTR Bought by SEB Asset Management AB

Posted by Stanley Muller on Jul 20th, 2026

SEB Asset Management AB bought a new position in shares of Ventas, Inc. (NYSE:VTR – Free Report) during the 1st quarter, HoldingsChannel reports. The institutional investor bought 406,354 shares of the real estate investment trust’s stock, valued at approximately $33,232,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Angeles Wealth Management LLC increased its holdings in shares of Ventas by 4.0% in the first quarter. Angeles Wealth Management LLC now owns 3,329 shares of the real estate investment trust’s stock worth $274,000 after acquiring an additional 128 shares in the last quarter. Bridgewater Advisors Inc. raised its position in shares of Ventas by 2.0% during the fourth quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after purchasing an additional 133 shares during the period. IHT Wealth Management LLC lifted its holdings in shares of Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after purchasing an additional 137 shares in the last quarter. True Wealth Design LLC lifted its holdings in shares of Ventas by 32.0% during the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock valued at $44,000 after purchasing an additional 138 shares in the last quarter. Finally, Cigna Investments Inc. New grew its position in shares of Ventas by 3.3% in the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after purchasing an additional 142 shares during the period. 94.18% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. This represents a 14.97% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. This trade represents a 3.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on VTR shares. Citigroup increased their target price on Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Barclays began coverage on shares of Ventas in a report on Tuesday, July 7th. They issued an “equal weight” rating and a $99.00 price target for the company. Royal Bank Of Canada increased their price objective on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. JPMorgan Chase & Co. raised their price objective on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. Finally, Raymond James Financial assumed coverage on shares of Ventas in a research report on Tuesday, June 16th. They issued an “outperform” rating and a $94.00 price objective on the stock. Fourteen investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and a consensus price target of $96.17.

View Our Latest Research Report on Ventas

Ventas Stock Up 0.0%

Shares of Ventas stock opened at $96.14 on Monday. The firm has a market cap of $46.74 billion, a PE ratio of 174.81, a P/E/G ratio of 2.07 and a beta of 0.70. The business’s 50 day simple moving average is $87.26 and its 200 day simple moving average is $84.19. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas, Inc. has a 52-week low of $65.15 and a 52-week high of $97.16.

Ventas (NYSE:VTR – Get Free Report) last released its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company’s revenue was up 22.0% compared to the same quarter last year. During the same period last year, the company earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, analysts predict that Ventas, Inc. will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, July 16th. Investors of record on Tuesday, June 30th were issued a dividend of $0.52 per share. The ex-dividend date was Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.2%. Ventas’s dividend payout ratio is presently 378.18%.

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.